U.S. Department of Justice. Ketamine Fast Facts. U.S. Department of Justice.
Drug Enforcement Administration. Drug Fact Sheet: Ketamine. Drug Enforcement Administration.
Drug Enforcement Administration. Ketalar, Ketaset, Ketajet, Ketavet, Vetamine, Vetaket, and Ketamine. Drug Enforcement Administration.
Drug Enforcement Administration. Drug Scheduling. Drug Enforcement Administration.
Drug Enforcement Administration. (July 13, 1999). Schedules of Controlled Substances: Placement of Ketamine into Schedule III. Federal Register.
Johns Hopkins Bloomberg School of Public Health. (January 26, 2024). What to Know About Ketamine. Johns Hopkins Bloomberg School of Public Health.
National Center for Biotechnology Information. (April 2020). A Review of Nonanesthetic Uses of Ketamine. National Center for Biotechnology Information.
National Center for Biotechnology Information. (January 30, 2024). Ketamine. StatPearls.
National Center for Biotechnology Information. (September 21, 2021). Test-retest reliability and cross-cultural applicability of DSM-5 ketamine use disorder diagnostic criteria. National Center for Biotechnology Information.
Substance Abuse and Mental Health Services Administration. (June 9, 2023). National Helpline for Mental Health, Drug, Alcohol Issues. Substance Abuse and Mental Health Services Administration.
Los Angeles County Department of Public Health. DSM-5 Substance Use Diagnosis Examples ICD-10 Code. Los Angeles County Department of Public Health.
National Center for Biotechnology Information. (January 27, 2023). Ketamine misuse: an update for primary care. National Center for Biotechnology Information.
National Center for Biotechnology Information. (January 17, 2022). Clinical and behavior characteristics of individuals who used ketamine. National Center for Biotechnology Information.
National Center for Biotechnology Information. (March 18, 2022). Brain Changes Associated With Long-Term Ketamine Abuse. National Center for Biotechnology Information.
National Center for Biotechnology Information. Multiorgan dysfunction related to chronic ketamine abuse. National Center for Biotechnology Information.
National Library of Medicine. (June 2008). Journey through the K-hole: phenomenological aspects of ketamine use. PubMed.
National Center for Biotechnology Information. (August 30, 2024). Ketamine – An Imperfect Wonder Drug?. National Center for Biotechnology Information.
National Library of Medicine. (May 26, 2001). A comparison of the acute and residual effects of ketamine. PubMed.
National Center for Biotechnology Information. (September 15, 2022). Ketamine-Induced Cystitis: A Comprehensive Review of the Urologic Complications of Illicit Use of Ketamine. National Center for Biotechnology Information.
National Center for Biotechnology Information. (October 30, 2012). Illicit ketamine and its bladder consequences: is it irreversible?. National Center for Biotechnology Information.
National Center for Biotechnology Information. (December 4, 2014). Long-Term Heavy Ketamine Use is Associated with Spatial Memory Impairment and Altered Hippocampal Functional Connectivity. National Center for Biotechnology Information.
National Center for Biotechnology Information. (December 2, 2021). Ketamine: A Potential Adjunct for Severe Benzodiazepine Withdrawal?. National Center for Biotechnology Information.
National Center for Biotechnology Information. (July 24, 2018). Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review. National Center for Biotechnology Information.
National Center for Biotechnology Information. (June 10, 2020). Extended Duration Ketamine Infusions in Critically Ill Children. National Center for Biotechnology Information.
National Center for Biotechnology Information. Providing Crisis-oriented and Recovery-based Treatment in Partial Hospitalization Programs for Persons with Severe Mental Illness. National Center for Biotechnology Information.
National Center for Biotechnology Information. Dialectical Behavior Therapy for Substance Abusers. National Center for Biotechnology Information.
National Center for Biotechnology Information. (December 31, 2016). Adapting Dialectical Behavior Therapy for the Treatment of Dissociative Symptoms. National Center for Biotechnology Information.
Old Dominion University. Group Treatment Effectiveness for Substance Use Disorders. Old Dominion University.
National Center for Biotechnology Information. (July 31, 2015). A family-oriented treatment program for youths with ketamine abuse or dependence. National Center for Biotechnology Information.
University of Washington. BH Crisis Management Guidance Clinical Practice Behavioral Health. University of Washington.
National Center for Biotechnology Information. (April 24, 2023). Crisis Intervention. StatPearls.
Centers for Medicare & Medicaid Services. (September 5, 2025). SHO #25-004. Centers for Medicare & Medicaid Services.
National Center for Biotechnology Information. (January 1, 2000). Chapter 5. Treatment Entry and Engagement. National Center for Biotechnology Information.